Genetic Test Evaluation

understanding how genetic tests impact patient management

Genetic Testing for Vascular Ehlers-Danlos Syndrome (vEDS)

March 29, 2019

This report evaluates the clinical utility of genetic testing for vascular Ehlers-Danlos syndrome (vEDS) in 3 patient populations:

  • Patients with vascular or digestive complications associated with vEDS.
  • Patients who have a first-degree relative with a molecularly confirmed diagnosis of vEDS.
  • Women with a personal or family history of vascular, digestive, or obstetric complications associated with vEDS for the purpose of family planning and/or pregnancy management.